587 related articles for article (PubMed ID: 20039311)
21. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
Idris AI; Landao-Bassonga E; Ralston SH
Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
[TBL] [Abstract][Full Text] [Related]
22. Aryl hydrocarbon receptor catabolic activity in bone metabolism is osteoclast dependent in vivo.
Yu TY; Kondo T; Matsumoto T; Fujii-Kuriyama Y; Imai Y
Biochem Biophys Res Commun; 2014 Jul; 450(1):416-22. PubMed ID: 24938130
[TBL] [Abstract][Full Text] [Related]
23. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
24. Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells.
Tsukamoto M; Menuki K; Murai T; Hatakeyama A; Takada S; Furukawa K; Sakai A
Bone; 2016 Apr; 85():70-80. PubMed ID: 26851124
[TBL] [Abstract][Full Text] [Related]
25. Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice.
Lee JW; Kobayashi Y; Nakamichi Y; Udagawa N; Takahashi N; Im NK; Seo HJ; Jeon WB; Yonezawa T; Cha BY; Woo JT
Biochem Pharmacol; 2010 Aug; 80(3):352-61. PubMed ID: 20412788
[TBL] [Abstract][Full Text] [Related]
26. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
[TBL] [Abstract][Full Text] [Related]
27. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Sasaki T
Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-17/20a inhibits glucocorticoid-induced osteoclast differentiation and function through targeting RANKL expression in osteoblast cells.
Shi C; Qi J; Huang P; Jiang M; Zhou Q; Zhou H; Kang H; Qian N; Yang Q; Guo L; Deng L
Bone; 2014 Nov; 68():67-75. PubMed ID: 25138550
[TBL] [Abstract][Full Text] [Related]
29. Constitutively active parathyroid hormone receptor signaling in cells in osteoblastic lineage suppresses mechanical unloading-induced bone resorption.
Ono N; Nakashima K; Schipani E; Hayata T; Ezura Y; Soma K; Kronenberg HM; Noda M
J Biol Chem; 2007 Aug; 282(35):25509-16. PubMed ID: 17500070
[TBL] [Abstract][Full Text] [Related]
30. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
31. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
[TBL] [Abstract][Full Text] [Related]
32. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
[TBL] [Abstract][Full Text] [Related]
33. IDH2 deficiency increases bone mass with reduced osteoclastogenesis by limiting RANKL expression in osteoblasts.
Lee SH; Lee SH; Lee JH; Park JW; Kim JE
Bone; 2019 Dec; 129():115056. PubMed ID: 31479775
[TBL] [Abstract][Full Text] [Related]
34. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
Nepal M; Choi HJ; Choi BY; Yang MS; Chae JI; Li L; Soh Y
Eur J Pharmacol; 2013 Sep; 715(1-3):96-104. PubMed ID: 23791609
[TBL] [Abstract][Full Text] [Related]
35. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
36. Anti-Osteoporotic Activity of Harpagoside by Upregulation of the BMP2 and Wnt Signaling Pathways in Osteoblasts and Suppression of Differentiation in Osteoclasts.
Chung HJ; Kim WK; Oh J; Kim MR; Shin JS; Lee J; Ha IH; Lee SK
J Nat Prod; 2017 Feb; 80(2):434-442. PubMed ID: 28106392
[TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking.
Nojiri H; Saita Y; Morikawa D; Kobayashi K; Tsuda C; Miyazaki T; Saito M; Marumo K; Yonezawa I; Kaneko K; Shirasawa T; Shimizu T
J Bone Miner Res; 2011 Nov; 26(11):2682-94. PubMed ID: 22025246
[TBL] [Abstract][Full Text] [Related]
38. MURF1 deficiency suppresses unloading-induced effects on osteoblasts and osteoclasts to lead to bone loss.
Kondo H; Ezura Y; Nakamoto T; Hayata T; Notomi T; Sorimachi H; Takeda S; Noda M
J Cell Biochem; 2011 Dec; 112(12):3525-30. PubMed ID: 21866567
[TBL] [Abstract][Full Text] [Related]
39. Suppressive effects of Anoectochilus formosanus extract on osteoclast formation in vitro and bone resorption in vivo.
Masuda K; Ikeuchi M; Koyama T; Yamaguchi K; Woo JT; Nishimura T; Yazawa K
J Bone Miner Metab; 2008; 26(2):123-9. PubMed ID: 18301967
[TBL] [Abstract][Full Text] [Related]
40. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.
Huang J; Yuan L; Wang X; Zhang TL; Wang K
Life Sci; 2007 Aug; 81(10):832-40. PubMed ID: 17764702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
